Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Langenbecks Arch Surg ; 408(1): 206, 2023 May 24.
Article in English | MEDLINE | ID: mdl-37221304

ABSTRACT

PURPOSE: Surgery of primary thyroid lymphoma (PTL) has been mostly limited to diagnostic work-up. This study aimed to further study its potential role. METHODS: This was a retrospective study from a multi-institutional registry of PTL patients. Clinical, diagnostic work-up (fine needle aspiration, FNA; core needle biopsy, CoreNB), contribution of surgery (open surgical biopsy, OpenSB; thyroidectomy), histology subtype, and outcome data were evaluated. RESULTS: Some 54 patients were studied. Diagnostic work-up included FNA in 47 patients, CoreNB in 11, and OpenSB in 21. CoreNB yielded the best sensitivity (90.9%). Thyroidectomy was performed in 14 patients with other diagnosis (incidental PTL), in 4 for diagnosis and in 4 for elective treatment of PTL. Incidental PTL was associated with not performed FNA nor CoreNB (OR 52.5; P = 0.008), mucosa-associated lymphoid tissue (MALT) subtype (OR 24.3; P = 0.012), and Hashimoto's thyroiditis (OR 11.1; P = 0.032). Lymphoma-related death (10 cases) mostly occurred within the first year after diagnosis and was associated with diffuse large B-cell (DLBC) subtype (OR 10.3; P = 0.018) and older patients (OR 1.08 for every 1-year increase; P = 0.010). There was a trend towards lower mortality rate in patients receiving thyroidectomy (2/22 versus 8/32, P = 0.172). CONCLUSION: Incidental PTL accounts for most of thyroid surgery cases and are associated with incomplete diagnostic work-up, Hashimoto's thyroiditis and MALT subtype. CoreNB appears to be the best tool for diagnosis. Most of PTL deaths occurred during the first year after diagnosis and mostly related to systemic treatment. Age and DLBC subtype are poor prognostic factors.


Subject(s)
Lymphoma , Thyroid Neoplasms , Thyroiditis , Humans , Retrospective Studies
2.
Transplant Proc ; 52(2): 534-536, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32081355

ABSTRACT

OBJECTIVE: To analyze predictors of survival involved in liver retransplantation (LRT), including the Rosen Model (RM). MATERIALS AND METHODS: This was a descriptive, observational, and unicentric study based on predictors of survival including patients who underwent LRT in a tertiary medical center between April 2002 and December 2018. Recipient, donor, and transplant data were collected, and RM score was calculated for every patient. Fisher exact test and Student t test were used for qualitative and quantitative variables, respectively. The Shapiro-Wilks test was applied to verify the normality of the sample. Survival differences between subgroups were checked using the log-rank test. Statistical significance was stated at P < .05. RESULTS: Among 32 retransplanted patients in this period, 17 (53.1%) survived more than 12 months after LRT. The results of statistical associations between prognostic factors and overall survival highlighted that an older recipient age was significantly correlated with a lower overall survival. The 3-month overall survival was 84.3%. Nineteen patients had a low risk according to RM, with a 3-month survival rate of 78.9%. Eight had a RM intermediate risk, with a survival rate of 21%. Despite the aforementioned data, the log-rank test did not find statistical differences in survival (P = .488). CONCLUSION: We should consider older recipient age as a negative prognostic factor of overall survival. Also, we should contemplate intermediate risk according to RM as an adverse predictor regarding survival in LRT. Both data are of interest regarding the indication or not of LRT and prioritization on the waiting list.


Subject(s)
Liver Transplantation/mortality , Patient Selection , Reoperation/mortality , Waiting Lists/mortality , Adult , Female , Humans , Liver Transplantation/methods , Male , Middle Aged , Reoperation/methods , Survival Rate
3.
Transplant Proc ; 52(2): 543-545, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32085861

ABSTRACT

AIM: To analyze the causes of liver retransplantation (LRT), which mostly depend on recipient factors. MATERIALS AND METHODS: A descriptive, observational, and unicentric study including patients who underwent an LRT in a tertiary medical center between April 2002 and December 2018. Recipient, donor, and liver transplant data were collected. RESULTS: During the period under review a total of 468 transplants were made; among them, 32 (6.8%) were LRT. The most common indication (25%) was hepatic artery thrombosis (HAT) developing ischemic cholangiopathy followed by chronic rejection (21.8%). Late LRT was performed in 71.8%. A total of 96.8% of donations were after brain death with a donor median age of 65 years. Six patients (18.7%) had HAT as a postoperative complication. The recipients' 3-, 6-, and 12-month overall survival was 72.7%, 54.6%, and 51.5%, respectively, and the 5-year was 46.8%. Leading cause of death was septic shock (42.1%). CONCLUSION: In our patients, the most common cause of LRT is HAT. We had an LRT rate of 6.8%, which is consistent with national and international registers.


Subject(s)
Hepatic Artery/surgery , Liver Transplantation/mortality , Postoperative Complications/surgery , Reoperation/mortality , Tissue Donors/statistics & numerical data , Adult , Aged , Female , Graft Survival , Humans , Liver Diseases/mortality , Liver Diseases/surgery , Liver Transplantation/methods , Male , Middle Aged , Postoperative Complications/etiology , Postoperative Complications/mortality , Reoperation/methods , Survival Rate , Tertiary Care Centers , Thrombosis/etiology , Thrombosis/mortality , Thrombosis/surgery
4.
Transplant Proc ; 50(2): 595-597, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29579862

ABSTRACT

OBJECTIVES: The score in the Model of End-stage Liver Disease, or MELD, is a good indicator of the survival in patients on the liver transplant waiting list. In this study, an analysis is performed on the benefits of liver transplant on those patients with a very high MELD score and who thus start from a very severe baseline state that could affect the surgical outcome. MATERIALS AND METHODS: A prospective study was conducted on a cohort of 331 patients that received a liver transplant between 2002 and 2014. The patients were divided into 2 groups according to the MELD score (<28 vs ≥28), and differences in age, postoperative complications, stay in the intensive care unit (ICU), hospital stay, and survival were compared. RESULTS: Of the total of 331 patients, 21 (6.3%) had a MELD score ≥ 28. The mean age of the group with MELD score ≥ 28 was lower than the age in the group with MEDL score < 28 (42.5 vs 53.7 years; P < .0001). No significant increase was observed in postoperative complications. Although there were also no differences in survival, the group with MELD score ≥ 28 did have a longer stay in ICU and a longer hospital stay (with a mean of 6.7 days in ICU and 41.5 days admission vs 4.1 and 26.9, respectively). CONCLUSIONS: A very high MELD score is associated with a longer stay in ICU and more days of hospital admission, although no differences were observed in postoperative complications or survival. Therefore, there does not seem to be any contraindication in transplantation in this group of patients.


Subject(s)
End Stage Liver Disease/mortality , End Stage Liver Disease/surgery , Liver Transplantation/mortality , Severity of Illness Index , Adult , Aged , Cohort Studies , Female , Humans , Intensive Care Units/statistics & numerical data , Length of Stay/statistics & numerical data , Liver Transplantation/adverse effects , Male , Middle Aged , Patient Selection , Postoperative Complications/epidemiology , Prospective Studies , Retrospective Studies
5.
Transplant Proc ; 50(2): 598-600, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29579863

ABSTRACT

BACKGROUND: Liver retransplantation (LrT) is the only therapeutic option for irreversible hepatic graft failure. Despite various improvements, its technical complexity entails a greater morbidity in the short and long term. The main goal of the study was to analyze the activity of LrT at our center, as well as its indications, timing, postoperative evolution, and the long-term survival of patients. METHODS: We designed a descriptive study of a cohort of patients who underwent LrT in a Spanish Hepatic Transplant Unit, between April 1, 2002 and December 31, 2015. RESULTS: A total of 366 primary orthotopic liver transplantations were performed, 20 of which were LrTs, resulting in a 5.5% retransplantation rate. The most frequent indication for LrT was hepatic artery thrombosis (HAT) (35%). Twenty-five percent of the LrTs were early retransplantations and 75% were late retransplantations. After LrT, 35% of the grafts showed liver dysfunction. The overall mortality rate was 45%: in early LrT this was 25% and in late LrT it was 46.7%. Graft actuarial survival at 1 month post-LrT was 75% and at 5 years it was 63.6%. The overall actuarial survival after LrT at month 1, year 1, year 3, and year 5 was 80%, 69.6%, 58.9%, and 50.5%, respectively. In the late LrT group, the results proved less favorable, so it is necessary to define the minimum acceptable result before proceeding to a second graft. CONCLUSION: Our LrT rate was lower than that reported by other groups in our country. The actuarial survival rates for graft and patient are comparable to those obtained by other groups.


Subject(s)
Graft Rejection/surgery , Liver Transplantation/mortality , Reoperation/mortality , Adult , Aged , Cohort Studies , Female , Humans , Liver Failure/etiology , Liver Failure/surgery , Male , Middle Aged , Postoperative Period , Spain/epidemiology , Survival Rate
6.
Transplant Proc ; 50(2): 605-609, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29579865

ABSTRACT

INTRODUCTION: The current imbalance between available donors and potential recipients for orthotopic liver transplantation (OLT) has led to a liberalization of organ acceptance criteria, increasing the risk of post-transplant complications such as early allograft dysfunction (EAD). Consequently, we need accurate criteria to detect patients with early poor graft function to guide the strategies of management. We evaluated the usefulness of two frequently used criteria: the definition from Olthoff et al and the Model for Early Allograft Function (MEAF) scoring. PATIENTS AND METHODS: Unicentric cohort study of patients undergoing OLT between January 1, 2010, and November 20, 2016. We performed a univariate study to detect donor, recipient, and transplant factors favoring EAD, defined both by Olthoff criteria and a MEAF score higher than 7. Finally, we developed a comparative survival analysis for cases having or not EAD. RESULTS: In all, 201 transplants met inclusion criteria. According to the stated cutoff for MEAF score, the frequency of EAD was 9.3%, with a significant association to low recipient body mass index and prolonged total graft ischemia time, resulting in lower patient 3-month postoperative survival. According to Olthoff criteria, EAD incidence was 22.1% and was associated with younger donor and recipient ages and higher Model for End-stage Liver Disease and Child-Pugh recipient scores. Its development resulted in lower graft and recipient survival at 3 months after OLT. CONCLUSION: MEAF score and Olthoff criteria are useful tools for detection of EAD. The latter could select more appropriately patients at risk, but its calculation cannot be done until the seventh day after OLT, unlike MEAF score, available on third day.


Subject(s)
Graft Survival/physiology , Primary Graft Dysfunction/diagnosis , Primary Graft Dysfunction/epidemiology , Severity of Illness Index , Adult , Allografts/physiopathology , Cohort Studies , Female , Humans , Incidence , Liver Transplantation/adverse effects , Male , Middle Aged , Primary Graft Dysfunction/physiopathology , Risk Factors , Time Factors , Tissue Donors , Transplantation, Homologous/adverse effects
7.
Transplant Proc ; 50(2): 628-630, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29579871

ABSTRACT

Liver transplantation offers patients with terminal liver disease an effective treatment accompanied by excellent quality of life, but it also has complications, such as hepatic artery thrombosis and development of ischemic cholangiopathy, described in 3%-17% of patients. It is a very important cause of morbidity and mortality. The objective of this report was to analyze the efficacy of the treatment they received in relation to the development of ischemic cholangiopathy and a comparative survival analysis and to propose prophylactic measures for high-risk patients.


Subject(s)
Bile Duct Diseases/etiology , Hepatic Artery/pathology , Liver Transplantation/adverse effects , Thrombosis/etiology , Female , Humans , Ischemia/etiology , Liver/blood supply , Liver Diseases/etiology , Male , Retrospective Studies , Treatment Outcome
8.
Transplant Proc ; 48(7): 2503-2505, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27742335

ABSTRACT

OBJECTIVE: The aim of this work was to determine the impact of obesity on the morbidity and mortality of liver transplantation (LT) recipients. METHODS: A single-center, observational-cohort, retrospective study was conducted in patients undergoing LT from January 2008 to December 2014 to compare complications and survival between those with body mass index (BMI) <35 kg/m2 and those with BMI ≥35 kg/m2. RESULTS: The study included 170 patients: 162 (95.3%) with BMI <35 kg/m2 and 8 (4.7%) with BMI ≥35 kg/m2. The groups significantly differed in overall mortality and graft survival: The risk of death was 3.54-fold higher (95% confidence interval, 1.39-9.03) and the mean graft survival was shorter (61 vs 21 mo; P = .001) in the group with BMI ≥35 kg/m2. The groups did not significantly differ in rates of biliary complications, arterial and portal vein thrombosis, retransplantation or reintervention, intraoperative requirement for blood products, length of intensive care unit stay, or post-reperfusion syndrome or rejection rates. CONCLUSIONS: Although no significant differences were found between these groups in post-transplantation complications, BMI ≥35 kg/m2 emerged as a mortality risk factor in these patients.


Subject(s)
Liver Transplantation , Obesity/complications , Adult , Body Mass Index , Cohort Studies , Female , Graft Survival , Humans , Liver Transplantation/mortality , Male , Middle Aged , Reoperation , Retrospective Studies , Risk Factors , Treatment Outcome
9.
Langenbecks Arch Surg ; 401(7): 937-942, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27080995

ABSTRACT

PURPOSE: Focused parathyroidectomy has been proven to be a safe technique for the treatment of single-gland primary hyperparathyroidism (PHPT). The CaPTHUS scoring model has been reported to be an accurate preoperative diagnostic tool for distinguishing single-gland (SGD) from multiglandular disease (MGD), including preoperative serum calcium and PTH values plus ultrasound and Sestamibi scanning. The purpose of the present study was to validate the CaPTHUS model for the population in southern Europe, since the North American and the European populations show different clinicopathological profiles in PHPT. METHODS: This is a retrospective review of a prospectively maintained database of patients diagnosed with PHPT who underwent surgical treatment in a single referral center. Differences between SGD and MGD groups were analyzed using chi-square and Fisher's exact tests for categorical variables and Student's t test for continuous variables. Overall diagnostic accuracy of the scoring model was assessed by the area under the receiver operating characteristic (ROC) curve (AUC). A p < 0.05 level was accepted as significant. RESULTS: From January 2001 to November 2014, 241 patients were included in the study, of whom 92.1 % had SGD and 71.8 % had a CaPTHUS score ≥3. SGD was distinguished from MGD (p < 0.001) using the dichotomous scoring model based on an AUC value of 0.762. Scores ≥3 had a sensitivity of 76.5 % and a positive predictive value of 96 % for SGD. CONCLUSIONS: Despite good test performance, a CaPTHUS score ≥3 does not discard MGD definitely. Intraoperative adjuncts are still needed to further reduce the risk of missing MGD during selective parathyroidectomy.


Subject(s)
Hyperparathyroidism, Primary/diagnosis , Aged , Calcium/blood , Female , Humans , Hyperparathyroidism, Primary/blood , Hyperparathyroidism, Primary/surgery , Male , Middle Aged , Parathyroid Hormone/blood , Parathyroidectomy , Predictive Value of Tests , ROC Curve , Radionuclide Imaging , Retrospective Studies , Spain , Ultrasonography
11.
Langenbecks Arch Surg ; 398(5): 709-16, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23624819

ABSTRACT

PURPOSE: Preoperative diagnosis of thyroid nodules with "follicular neoplasm" (FN) based on fine-needle aspiration cytology (FNAC) forces thyroidectomy to exclude malignancy. This study explores if (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG-PET/CT) provides information enough to prevent unnecessary thyroidectomies in this clinical setting. METHODS: This is a prospective study involving 46 consecutive patients scheduled for thyroidectomy due to follicular neoplasm diagnosis in FNAC (36 follicular, 10 Hürthle cell neoplasms, Bethesda classification) since January 2009 until April 2012. All patients underwent preoperative (18)F-FDG-PET/CT. Abnormal (18)F-FDG thyroid uptake was assessed visually and by measuring the maximum standard uptake value (SUV max). Results were compared with definitive pathology reports. RESULTS: Thirteen out of 46 patients (28.3 %) were finally diagnosed with thyroid cancer. Focal uptake correlated with a greater risk of malignancy (p = 0.009). (18)F-FDG-PET/CT focal uptake showed sensitivity, specificity, positive and negative predictive values and overall accuracy of 92.3, 48.5, 41.4, 94.1 and 60.9 %, respectively. The optimal threshold SUV max to discriminate malignancy was 4.2 with an area under receiver-operating characteristic curve of 0.76 (95 % confidence interval, 0.60-0.90). Use of (18)F-FDG-PET/CT could reduce by 13-25 % the number of thyroidectomies performed for definitive benign nodules. However, it has demonstrated worse predictive ability in the subgroup of patients with diffuse uptake, oncocytic pattern in FNAC and lesions smaller than 2. CONCLUSIONS: (18)F-FDG-PET/CT can play a role in the management of thyroid nodules larger than 2 cm cytologically reported as follicular neoplasm without oncocytic differentiation, allowing the avoidance of a significant number of thyroidectomies for definitive benign lesions.


Subject(s)
Adenocarcinoma, Follicular/diagnostic imaging , Adenocarcinoma, Follicular/surgery , Multimodal Imaging , Positron-Emission Tomography , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/surgery , Thyroidectomy , Tomography, X-Ray Computed , Adult , Aged , Biopsy, Fine-Needle , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Prospective Studies , Radiopharmaceuticals , Unnecessary Procedures
13.
Actas Urol Esp ; 27(6): 462-4, 2003 Jun.
Article in Spanish | MEDLINE | ID: mdl-12918154

ABSTRACT

We present a case report of a renal angiomyolipoma with the special feature of its big size at the moment of the diagnosis. It is appreciated an important alteration of the kidney morphology and the repercussion produced in the rest of the abdominal organs. Due to this an exeresis with nefrectomy is performed. We do a bibliographic review and we analyzed the relevant aspects of this tumour.


Subject(s)
Angiomyolipoma/pathology , Kidney Neoplasms/pathology , Adult , Angiomyolipoma/surgery , Female , Humans , Kidney Neoplasms/surgery , Nephrectomy
14.
Actas urol. esp ; 27(6): 462-464, jun. 2003.
Article in Es | IBECS | ID: ibc-24110

ABSTRACT

Presentamos un caso de angiomiolipoma renal cuya peculiaridad es el gran tamaño que tiene en el momento del diagnostico lo que ocasiona una alteración de la morfología del riñón afecto, así como al resto de vísceras de la cavidad abdominal. Por este motivo se interviene realizando exéresis de la masa con nefrectomía. Realizamos una revisión bibliográfica de este tumor analizando sus peculiaridades y aspectos más destacables (AU)


Subject(s)
Adult , Female , Humans , Angiomyolipoma , Nephrectomy , Kidney Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL
...